Tatiana López del Río
Director Ejecutivo en Nanogap Sub NM Powder SA .
Perfil
Tatiana López del Río is the founder of Nanogap Sub NM Powder SA, where she holds the titles of Chairman, President & Chief Executive Officer since 2006.
She is currently working as a Director at Arjuna Therapeutics.
Cargos activos de Tatiana López del Río
Empresas | Cargo | Inicio |
---|---|---|
Nanogap Sub NM Powder SA
Nanogap Sub NM Powder SA Miscellaneous Commercial ServicesCommercial Services Nanogap Sub NM Powder SA provides research and development of nanotechnology materials. It serves in the medical, electronic and packaging industries. The firm offers atomic quantum clusters and nanoparticle dispersions in a variety of carrier liquids and solutions. The company was founded by Jose Rivas, Tatiana Lopez del Rio, Vazquez Carlos Vazquez and Arturo Lopez Quintelas in 2006 and is headquartered in Ames, Spain. | Director Ejecutivo | 01/01/2006 |
Arjuna Therapeutics
Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Nanogap Sub NM Powder SA
Nanogap Sub NM Powder SA Miscellaneous Commercial ServicesCommercial Services Nanogap Sub NM Powder SA provides research and development of nanotechnology materials. It serves in the medical, electronic and packaging industries. The firm offers atomic quantum clusters and nanoparticle dispersions in a variety of carrier liquids and solutions. The company was founded by Jose Rivas, Tatiana Lopez del Rio, Vazquez Carlos Vazquez and Arturo Lopez Quintelas in 2006 and is headquartered in Ames, Spain. | Commercial Services |
Arjuna Therapeutics
Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | Health Services |
- Bolsa de valores
- Insiders
- Tatiana López del Río